Drug archive
Irinotecan (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antineoplastic
Description
Irinotecan (eye-ri-noe-TEE-kan) belongs to the group of medicines called antineoplastics. It is used to treat cancer of the colon or rectum.
Irinotecan interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal cells may also be affected by the medicine, other effects may also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern. Some effects may occur after treatment with irinotecan has been stopped. Be sure that you have discussed with your doctor the possible side effects of this medicine as well as the good it can do.
This medicine is available only with your doctor's prescription, in the following dosage form(s):
- Injection (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Camptosar
In Canada -
- Camptosar
Another commonly used name is CPT-11 .